The Society of Gynecologic Oncology and ASCCP endorse this document. USPSTF Cervical Cancer Screening Recommendations for Average-Risk. As with the updates, the new ACS/ASCCP/ASCP guidelines suggest a . Comparison of Cervical Cancer Screening Guidelines. Co-testing is preferable to using a Pap test alone for women ages 30– 1 ACS, ASCCP, & ASCP guidelines update In March
|Published (Last):||26 March 2009|
|PDF File Size:||8.89 Mb|
|ePub File Size:||9.59 Mb|
|Price:||Free* [*Free Regsitration Required]|
A Decision Analysis for the U. Sign up for the free AFP email table of contents. Women who have received the HPV vaccination. Why new guidelines now? Cytology every three years liquid or conventional.
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or guidelinse cytologic abnormalities.
Guidelines – ASCCP
Preventive Services Task Force recommendation statement. This suggests that less aggressive assessment will minimize potential harms of managing abnormalities likely to resolve spontaneously.
Co-testing with cytology and HPV testing every five years or every three years with cytology alone. Women 30 to guifelines years of age should be screened with cytology and HPV testing i.
Despite this, more than 10 million women continue to have this unnecessary screening. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: New research shows lower risk of existing abnormalities than previously thought and provides guidance on use of HPV testing.
How should I manage women with discordant cotesting results? ASCCP-sponsored consensus recommendations for the management of abnormal cytology results were published in Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: Practice Advisories are reviewed periodically for reaffirmation, revision, withdrawal or incorporation into other ACOG guidelines. Most new HPV infections in women older than 65 years clear spontaneously.
Providers need guidance on how to manage women with discordant results. Overtreatment leads to net harm in young women.
Follow-Up of Abnormal Screening Tests
Women with similar risks should be managed similarly. How do I manage my patients? The guidelines are based on a systematic evidence review. Information from references 1 and In the interim, ACOG affirms its current cervical cancer screening guidelines 2which encompass all three cervical cancer screening strategies cervical cytology alone, hrHPV testing alone, and co-testing.
Women who have undergone hysterectomy.
ACS/ASCCP/ASCP Guidelines for the Early Detection of Cervical Cancer
ascco What HPV tests should I use? Discontinue if three negative Pap smear results or two negative HPV test results in past 10 years, if most recent test was within the past five years. Therefore, these women should not be referred directly for colposcopy. Address correspondence to Patricia L. The new USPSTF recommendations emphasize that the choice of screening strategy should consider the balance of benefit disease detection and potential harms more frequent follow-up testing, invasive diagnostic procedures, and unnecessary treatment in women with false-positive results and involve shared decision making between patients and their health care providers.
Continue reading from September 15, Previous: This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care.
Same as for unvaccinated women. Thank you Your feedback guidelies been sent. Want to use this article elsewhere? There is no role for testing for low-risk genotypes, and tests guidelinnes low-risk HPV should not be performed. The guidelines state that women younger than 21 years should not be guidelnes for cervical cancer, regardless of age of sexual initiation or other risk factors.
For women 21 to 29 years of age, the new guidelines recommend screening with cytology alone every three years. For women years of age, routine screening with cytology in 3 years is indicated. It is not intended to substitute for the independent professional judgment of the treating clinician.
J Natl Cancer Inst. How is management modified in women years of age? Women’s Health Care Physicians. This varies by age: